Details of the Drug

General Information of Drug (ID: DMJ682M)

Drug Name

PF-06649751

Indication

Disease Entry	ICD 11	Status	REF
Parkinson disease	8A00.0	Phase 1	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C19H16F3N3O3
Canonical SMILES: CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C
InChI: 1S/C19H16F3N3O3/c1-10-9-12(28-17-14(19(20,21)22)5-4-8-23-17)6-7-13(10)15-11(2)16(26)24-18(27)25(15)3/h4-9H,1-3H3,(H,24,26,27)
InChIKey: AKQXQLUNFKDZBN-UHFFFAOYSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01981694) A Phase I Trial to Investigate the Safety and Tolerability of PF-06649751. U.S. National Institutes of Health.